Logo-ijhpm
Int J Health Policy Manag. 2022;11(10): 2327-2336. doi: 10.34172/ijhpm.2021.159
PMID: 34923809        PMCID: PMC9808268

Original Article

Evidence-Informed Deliberative Processes for Health Benefit Package Design – Part II: A Practical Guide

Wija Oortwijn * ORCID, Maarten Jansen ORCID, Rob Baltussen ORCID

Cited by CrossRef:

1- Wale J, Sehmi K, Kamoga R, Ssekubugu R. Civil society and medical product access in Africa: Lessons from COVID-19. Front Med Technol. 2023;5 [Crossref]
2- Stratil J, Jakubowski E, Pruskil S, Siebert U, Arnold L. Herausforderungen bei der Entwicklung von Leitlinien für Maßnahmen zur Förderung und Aufrechterhaltung der öffentlichen Gesundheit. 2024;32(4):292 [Crossref]
3- Surgey G, Curocichin G, Garabajiu M, Novakovic T, Pana A, Oortwijn W. The development of a roadmap for Health Technology Assessment implementation in Moldova. F1000Res. 2024;13:518 [Crossref]
4- Moradzadeh M, Karamouzian M, Najafizadeh S, Yazdi-Feyzabadi V, Haghdoost A. International Journal of Health Policy and Management (IJHPM): A Decade of Advancing Knowledge and Influencing Global Health Policy (2013-2023). Int J Health Policy Manag. 2023;12:8124 [Crossref]
5- Bidonde J, Lauvrak V, Ananthakrishnan A, Kingkaew P, Peacocke E. Topic identification, selection, and prioritization for health technology assessment in selected countries: a mixed study design. Cost Eff Resour Alloc. 2024;22(1) [Crossref]
6- Khor S, Elsisi Z, Carlson J. How Much Does the US Public Value Equity in Health? A Systematic Review. Value in Health. 2023;26(3):418 [Crossref]
7- Peacocke E, Heupink L, Ananthakrishnan A, Frønsdal K. Is it the Right Topic? An Overlooked Stage in the Institutionalization of Health Technology Assessment. Health Systems & Reform. 2023;9(3) [Crossref]
8- Surgey G, Curocichin G, Garabajiu M, Novakovic T, Pana A, Oortwijn W. The development of a roadmap for Health Technology Assessment implementation in Moldova. F1000Res. 2024;13:518 [Crossref]
9- Baltussen R, Jansen M, Akhtar S, Bijlmakers L, Torres-Rueda S, Khalid M, Raza W, Huda M, Surgey G, Zulfiqar W, Vassall A, Zaidi R, Siddiqi S, Alwan A. The Use of Evidence-Informed Deliberative Processes for Designing the Essential Package of Health Services in Pakistan. Int J Health Policy Manag. 2023;12:8004 [Crossref]
10- Son K. Public value judgments about the criteria for reimbursement of medicines in South Korea. Expert Review of Pharmacoeconomics & Outcomes Research. 2025;25(1):53 [Crossref]
11- Alwan A, Jallah W, Baltussen R, Carballo M, Gonyon E, Gudumac I, Haghparast-Bidgoli H, Jacobs G, Abou Jaoude G, Kateh F, Logan G, Skordis J. Designing an evidence-informed package of essential health services for Universal Health Coverage: lessons learnt and challenges to implementation in Liberia. BMJ Glob Health. 2024;9(6):e014904 [Crossref]
12- Baltussen R, Mwalim O, Blanchet K, Carballo M, Eregata G, Hailu A, Huda M, Jama M, Johansson K, Reynolds T, Raza W, Mallender J, Majdzadeh R. Decision-making processes for essential packages of health services: experience from six countries. BMJ Glob Health. 2023;8(Suppl 1):e010704 [Crossref]